Presentation at ACLC2024 Hong-Kong
Federation of Asian Clinical Oncology (FACO)
2024年10月17日木曜日
ACLC2024香港にて発表
2024年8月16日金曜日
PC-CURE-1がHepato-Biliary-Pancreatic Sciencesに掲載
PC-CURE-1 paper published : Hepato-Biliary-Pancreatic Sciences
2024年5月5日日曜日
Treatment choice for c-Stage III NSCLCフォーム入力開始
Treatment choice for c-Stage III NSCLC survey enrollment starts
The fourth international collaborative project to be implemented by FACO is a survey on Treatment Choice for c-Stage III Non-Small Cell Lung Cancer, targeting specialists in medical oncologist, surgical oncologist, and radiational oncologist from Japan, Korea, and China. Dr. Hidehito Horinouchi (National Cancer Center Hospital) led a survey item input format using Microsoft Forms.
This survey asks researchers to indicate their clinical status, such as clinical stage and lymph node metastasis, and to answer their first-choice treatment.
There is a similar survey conducted by Dr. Horinouchi at a JCOG facility in Japan, but this survey is conducted in three East Asian countries and is conducted from an international perspective.
The deadline for case registration is May 13, 2024.
2023年9月10日日曜日
第2回FACO肺癌アカデミック委員会合開催(シンガポール)
The 2nd FACO Lung Cancer Academic Committee Meeting in Singapore
2023年9月8日金曜日
第11回FACO学術集会
The 11th International Conference of FACO in conjunction with KSMO2023 Congress
2023年7月11日火曜日
第1回FACO肺癌Academic Committee会合
The 1st FACO Lung Cancer Academic Committee Meeting
FACOでは、胃癌・乳癌・膵癌の試験を日中韓で行ってきましたが、次の国際試験の療育として、肺癌が候補となっています。
光冨徹哉先生が中心となり、日中韓の研究者たちが第1回会合をZoomにて開催しました。
FACO has conducted clinical trials for gastric, breast, and pancreatic cancer with the collaboration of China, Japan and Korea, and lung cancer is now a candidate for the next international trial.
Led by Dr. Tetsuya Mitsutomi, investigators from China, Japan, Korea held the first meeting at Zoom.
2023年4月7日金曜日
PC-CURE-1 第109回日本消化器病学会総会での発表
PC-CURE-1, presentation at the 109th General Meeting of the Japanese Society of Gastroenterology